Modulation of acetylcholine release at the neuromuscular junction

At the neuromuscular junction, the release of acetylcholine from presynaptic motor nerve terminals is a critical step in neurotransmission leading to muscle contraction[1][5][3]. Modulation of this process involves several molecular mechanisms, including presynaptic muscarinic and nicotinic receptors that regulate the amount and synchrony of ACh release[2][7]; SNARE proteins and synaptotagmin mediate vesicle fusion and exocytosis of ACh; and voltage-gated calcium channels trigger this process in response to nerve action potentials[1][5]. Drugs that manipulate these pathways are critical in the management of neuromuscular diseases and anesthesia, but adverse effects can arise when this balance is disturbed.

Other names

Modulation of acetylcholine release at NMJACh release modulation at neuromuscular junctionPresynaptic modulation of acetylcholine at NMJ

Inhibition of acetylcholinesterase increases ACh levels in the synaptic cleft; Neuromuscular blockers inhibit presynaptic or postsynaptic ACh receptors, blocking transmission; Presynaptic autoreceptors (muscarinic and nicotinic) modulate the quantity and timing of ACh release; SNARE protein inhibitors interfere with vesicle fusion and neurotransmitter release